Roche has had plenty of time to figure out what its options...

Roche has had plenty of time to figure out what its options are regarding the licensing of the patents. There are too many potential suppliers to undertake individual negotiations with each company. Roche needs to simply identify the relevant terms it will impose on generic suppliers and offer open licenses to anyone who can comply.